X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 08/Aug 13:50

Allogene (ALLO) Posts Narrower Than Expected Loss in Q2

Allogene's (ALLO) second-quarter earnings beat estimates but sales miss the mark. It expects to submit a regulatory filing with the FDA for its lead pipeline drug in large B-cell lymphoma indication by 2027.

Articles similaires

Sorry! Image not available at this time

Genesco Q2 Loss Narrower Than Expected, Comparable Sales Fall 2%

zacks.com - 09/Sep 16:30

GCO reports a narrower-than-expected loss per share and sales beat in second-quarter fiscal 2025. E-commerce comps rose 8%.

Sorry! Image not available at this time

Genesco Q2 Loss Narrower Than Expected, Comparable Sales Fall 2%

zacks.com - 09/Sep 16:30

GCO reports a narrower-than-expected loss per share and sales beat in second-quarter fiscal 2025. E-commerce comps rose 8%.

Sorry! Image not available at this time

Foot Locker Q2 Loss Narrower Than Expected, Margin View Down

zacks.com - 28/Aug 13:49

FL Q2 revenues beat estimates. Comparable sales increase 2.6% year over year, driven by 5.2% comps growth in global Foot Locker and Kids Foot Locker...

Sorry! Image not available at this time

American Eagle Q2 Earnings Beat Estimates, Stock Down on Revenue Miss

zacks.com - 29/Aug 17:00

AEO posts revenue miss in second-quarter fiscal 2024. It anticipates operating income to be in the range of $120-$125 million for the fiscal third...

Sorry! Image not available at this time

ASO Q2 Earnings Meet Estimates, Sales Miss, '24 Guidance Down

zacks.com - 13:08

Academy Sports' second-quarter fiscal 2024 results reflect soft demand trends due to macroeconomic uncertainties.

Sorry! Image not available at this time

Virco's Q2 Earnings Beat Estimates, Revenues Miss, Stock Falls

zacks.com - 10/Sep 13:01

VIRC's second-quarter fiscal 2024 results benefit from higher factory output and improved operating efficiencies, along with a significant...

Sorry! Image not available at this time

Virco's Q2 Earnings Beat Estimates, Revenues Miss, Stock Falls

zacks.com - 10/Sep 13:01

VIRC's second-quarter fiscal 2024 results benefit from higher factory output and improved operating efficiencies, along with a significant...

Sorry! Image not available at this time

Zumiez's Q2 Loss Narrower Than Expected, Comparable Sales Improve Y/Y

zacks.com - 06/Sep 16:00

ZUMZ's fiscal Q2 results are aided by a strong North America business, reflecting comps growth in June and July, particularly driven by the onset of...

Sorry! Image not available at this time

Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review

zacks.com - 28/Aug 14:25

SLNO stock gains 6.3% as FDA accepts regulatory filing for lead candidate, DCCR, to treat hyperphagia associated with PWS under Priority Review.

Sorry! Image not available at this time

Lululemon's Q2 Mixed: Earnings Beat, Sales Lag Estimates in Americas

zacks.com - 30/Aug 16:51

LULU Q2 results reflect soft sales trends on continued weakness in the Americas, wherein comps dipped 3%. Its expense control aids EPS.